Spruce Biosciences, Inc. Profile Avatar - Palmy Investing

Spruce Biosciences, Inc.

Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce s…

Biotechnology
US, Daly City [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Spruce Biosciences, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of SPRB's Analysis
CIK: 1683553 CUSIP: 85209E109 ISIN: US85209E1091 LEI: - UEI: -
Secondary Listings
SPRB has no secondary listings inside our databases.